Cognex Corp. (NASDAQ: CGNX) closed the day trading at $40.67 down -0.49% from the previous closing price of $40.87. In other words, the price has decreased by -$0.20 from its previous closing price. On the day, 1296405 shares were traded.
Ratios:
For a better understanding of CGNX, let’s look at its different ratios. It provided that stocks Price–to–Cash (P/C) ratio for the trailing twelve months (TTM) is standing at 21.02 whereas its Price-to-Free Cash Flow (P/FCF) for the term is 77.70. For the most recent quarter (mrq), Quick Ratio is recorded 3.31 and its Current Ratio is at 4.38. In the meantime, Its Debt-to-Equity ratio is 0.05 whereas as Long-Term Debt/Eq ratio is at 0.05.
Upgrades & Downgrades
In addition, analysts’ ratings and any changes thereto give investors an idea of the stock’s future direction. In the most recent recommendation for this company, Truist on March 14, 2024, initiated with a Buy rating and assigned the stock a target price of $47.
On October 05, 2023, Exane BNP Paribas started tracking the stock assigning a Outperform rating and target price of $55.
Insider Transactions:
The insider trade also gives investors a glimpse into the future direction of stock prices, which can be beneficial to investors. A recent insider transaction in this stock occurred on Mar 12 ’24 when Kuechen Joerg sold 5,331 shares for $40.93 per share. The transaction valued at 218,212 led to the insider holds 2,934 shares of the business.
Gerst Carl sold 6,782 shares of CGNX for $274,923 on Mar 06 ’24. The EVP, Vision & ID Products now owns 0 shares after completing the transaction at $40.54 per share.
Valuation Measures:
Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, CGNX now has a Market Capitalization of 6.99B and an Enterprise Value of 6.73B. As of this moment, Cognex’s Price-to-Earnings (P/E) ratio for their current fiscal year is 62.33, and their Forward P/E ratio for the next fiscal year is 34.05. The expected Price-to-Earnings-to-Growth (PEG) calculation for the next 5 years is 20.99. For the stock, the TTM Price-to-Sale (P/S) ratio is 8.33 while its Price-to-Book (P/B) ratio in mrq is 4.64. Its current Enterprise Value per Revenue stands at 8.04 whereas that against EBITDA is 46.56.
Stock Price History:
Over the past 52 weeks, CGNX has reached a high of $59.51, while it has fallen to a 52-week low of $34.28. The 50-Day Moving Average of the stock is 38.40, while the 200-Day Moving Average is calculated to be 43.75.
Shares Statistics:
Over the past 3-months, CGNX traded about 1.73M shares per day on average, while over the past 10 days, CGNX traded about 1.48M shares per day. A total of 171.60M shares are outstanding, with a floating share count of 171.17M. Insiders hold about 0.27% of the company’s shares, while institutions hold 95.20% stake in the company. Shares short for CGNX as of Feb 29, 2024 were 4.45M with a Short Ratio of 2.58, compared to 4.43M on Jan 31, 2024. Therefore, it implies a Short% of Shares Outstanding of 2.59% and a Short% of Float of 2.60%.
Dividends & Splits
CGNX’s forward annual dividend rate is 0.29, up from 0.28 a year ago. Against a Trailing Annual Dividend Yield of 0.70%, it implies a Forward Annual Dividend Yield of 0.74%. The stock’s 5-year Average Dividend Yield is 0.44. The current Payout Ratio is 43.64% for CGNX, which recently paid a dividend on Mar 14, 2024 with an ex-dividend date of Feb 28, 2024. Stock splits for the company last occurred on Dec 04, 2017 when the company split stock in a 2:1 ratio.
Earnings Estimates
Current recommendations for the stock of the company come from 14 analysts. On average, analysts expect EPS of $0.08 for the current quarter, with a high estimate of $0.15 and a low estimate of $0.04, while EPS last year was $0.13. The consensus estimate for the next quarter is $0.21, with high estimates of $0.35 and low estimates of $0.15.
Analysts are recommending an EPS of between $0.95 and $0.59 for the fiscal current year, implying an average EPS of $0.78. EPS for the following year is $1.2, with 16 analysts recommending between $1.38 and $0.94.
Revenue Estimates
A total of 17 analysts have provided revenue estimates for CGNX’s current fiscal year. The highest revenue estimate was $980.71M, while the lowest revenue estimate was $882.34M, resulting in an average revenue estimate of $937.51M. In the same quarter a year ago, actual revenue was $837.55M, up 11.90% from the average estimate. Based on 17 analysts’ estimates, the company’s revenue will be $1.07B in the next fiscal year. The high estimate is $1.15B and the low estimate is $961.66M. The average revenue growth estimate for next year is up 14.40% from the average revenue estimate for this year.
